UCLA CTSI K Workshop - July 28, 2022
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence" presented by Dr. Christopher Evans, PhD
This document provides an outline and overview for writing a research proposal. It discusses reasons for conducting research such as contributing to knowledge and solving problems. A proposal and research proposal are defined as plans for carrying out a task or study. Guidelines are provided for preparing to write a proposal, including contents. A proposal should have chapters on introduction, literature review, and methodology. The introduction states the problem, purpose, significance and research questions or hypotheses. The literature review establishes the theoretical or conceptual framework and reviews related work. The methodology describes the research design, participants, instruments, and analysis plan. Ethical considerations must also be addressed.
What do you need to know before and while working on a clinical trial? This slide deck tells you more about the things you need to remember when preparing to publish your clinical trial, from developing a research protocol and getting informed consent from study participants to registering your trial and preparing a clinical trial manuscript.
The document discusses configuring replication between two Oracle RAC clusters, Silo A and Silo B, located in Utah and New Jersey respectively, using SharePlex. It outlines setting up SharePlex, including: creating required tablespaces and TNS entries; installing and configuring SharePlex on each cluster; creating SharePlex configuration files to replicate data between the clusters bidirectionally; and starting the SharePlex processes. The goal is to maintain high availability and meet a 99.9% uptime SLA for critical application data replicated between the clusters.
This document provides an overview of impact evaluation and randomized control trials. It discusses J-PAL, an organization that uses randomized evaluations to answer policy questions and reduce poverty. J-PAL has offices around the world and works on various policy areas. The presentation then discusses why evaluation is important to determine what programs are effective and how to improve them. It provides an example of evaluating a water and sanitation program in Kenya, covering needs assessment, program theory, process evaluation, and using a randomized control trial to conduct impact evaluation and compare cost-effectiveness. The presentation emphasizes that randomized evaluations can provide the most robust evidence of a program's impact when certain criteria are met.
The document contains details of SQL execution plans and statistics for queries run against tables A and B. It includes the execution plan details showing the operations performed at each step including table access methods and indexes used. It also shows statistics on the performance of the queries such as elapsed time, CPU time, number of executions and rows processed.
PhillyCooke eCTD Submissions for Ad-PromoDale Cooke
This presentation was initially delivered at the NJ/NY RAPS chapter on November 19, 2015. It reviews the FDA guidance on providing ad-promo submissions in electronic and print formats, explains the complex nature of the guidance and its scope, and includes the latest from FDA on how the guidance is being implemented.
This document provides an outline and overview for writing a research proposal. It discusses reasons for conducting research such as contributing to knowledge and solving problems. A proposal and research proposal are defined as plans for carrying out a task or study. Guidelines are provided for preparing to write a proposal, including contents. A proposal should have chapters on introduction, literature review, and methodology. The introduction states the problem, purpose, significance and research questions or hypotheses. The literature review establishes the theoretical or conceptual framework and reviews related work. The methodology describes the research design, participants, instruments, and analysis plan. Ethical considerations must also be addressed.
What do you need to know before and while working on a clinical trial? This slide deck tells you more about the things you need to remember when preparing to publish your clinical trial, from developing a research protocol and getting informed consent from study participants to registering your trial and preparing a clinical trial manuscript.
The document discusses configuring replication between two Oracle RAC clusters, Silo A and Silo B, located in Utah and New Jersey respectively, using SharePlex. It outlines setting up SharePlex, including: creating required tablespaces and TNS entries; installing and configuring SharePlex on each cluster; creating SharePlex configuration files to replicate data between the clusters bidirectionally; and starting the SharePlex processes. The goal is to maintain high availability and meet a 99.9% uptime SLA for critical application data replicated between the clusters.
This document provides an overview of impact evaluation and randomized control trials. It discusses J-PAL, an organization that uses randomized evaluations to answer policy questions and reduce poverty. J-PAL has offices around the world and works on various policy areas. The presentation then discusses why evaluation is important to determine what programs are effective and how to improve them. It provides an example of evaluating a water and sanitation program in Kenya, covering needs assessment, program theory, process evaluation, and using a randomized control trial to conduct impact evaluation and compare cost-effectiveness. The presentation emphasizes that randomized evaluations can provide the most robust evidence of a program's impact when certain criteria are met.
The document contains details of SQL execution plans and statistics for queries run against tables A and B. It includes the execution plan details showing the operations performed at each step including table access methods and indexes used. It also shows statistics on the performance of the queries such as elapsed time, CPU time, number of executions and rows processed.
PhillyCooke eCTD Submissions for Ad-PromoDale Cooke
This presentation was initially delivered at the NJ/NY RAPS chapter on November 19, 2015. It reviews the FDA guidance on providing ad-promo submissions in electronic and print formats, explains the complex nature of the guidance and its scope, and includes the latest from FDA on how the guidance is being implemented.
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Co-Director, UCLA CTSI KL2 Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
This document provides information about the K99/R00 Career Transition Award program from the National Institutes of Health (NIH). The K99 phase provides 1-2 years of mentored support for postdoctoral researchers, while the R00 phase provides 1-3 years of independent research support contingent on securing an independent research position. Eligible candidates must have a terminal degree and no more than 4 years of postdoctoral experience. The program aims to support highly motivated researchers in transitioning to independent research careers through a period of mentored research followed by independent funding.
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
UCLA CTSI K Workshop - February 4, 2016
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, Research Education, Training and Career Development Program
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
This document provides information for prospective graduate students about pursuing a graduate degree in life sciences. It discusses the skills and career opportunities that come with a graduate degree, including research, teaching, industry careers, and more. It provides tips for applying to graduate school, including identifying suitable supervisors and labs, drafting a strong application, and applying for funding. Overall, it encourages students to pursue graduate education if interested in a career with continual learning where they can contribute to important scientific fields.
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Transitioning to Independence: Tips for Writing NIH Career (K) Award Applicat...HopkinsCFAR
The document provides tips for writing NIH Career (K) award applications, including:
1. It outlines the various K award mechanisms for different career stages from postdoctoral training through assistant professor level.
2. It discusses the application process and identifies important elements of a successful application such as the research plan, career development plan, mentors, and institutional commitment.
3. It emphasizes starting early, getting feedback, and paying attention to eligibility requirements and submission guidelines.
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
How to Anticipate and Plan for an R Grant Application (2020)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
This document provides information to help navigate career development opportunities at the National Institutes of Health (NIH). It describes the various NIH Institutes and Centers and their funding priorities. It also outlines the different types of grants, fellowships, and awards available at different career stages, from training programs to independent research awards. Key resources covered include the NIH RePORTER database to find funded projects, program officers to discuss ideas, and the NIH Research Training website for more details on specific opportunities. The document aims to guide scientists seeking NIH support in identifying the right Institute and program to fit their research area and career stage.
How to Anticipate and Plan for an R Grant Application - 2023UCLA CTSI
CTSI R Workshop: How to Anticipate and Plan for an R Grant Application.
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application. (2022)UCLA CTSI
Carol Mangione provides strategies for early career researchers to successfully transition from a K award to an R01 grant. She emphasizes building relationships at NIH, identifying the best fitting funding opportunities, and making the most of preliminary K award research. Researchers should publish findings, present at conferences, and collaborate with senior scientists. When preparing an R01 application, researchers should clearly outline the proposed project based on significant preliminary findings and check that the research aims have not already been funded.
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
More Related Content
Similar to K99 Award: the NIH "Pathway to Independence"
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Co-Director, UCLA CTSI KL2 Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
This document provides information about the K99/R00 Career Transition Award program from the National Institutes of Health (NIH). The K99 phase provides 1-2 years of mentored support for postdoctoral researchers, while the R00 phase provides 1-3 years of independent research support contingent on securing an independent research position. Eligible candidates must have a terminal degree and no more than 4 years of postdoctoral experience. The program aims to support highly motivated researchers in transitioning to independent research careers through a period of mentored research followed by independent funding.
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
UCLA CTSI K Workshop - February 4, 2016
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, Research Education, Training and Career Development Program
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
This document provides information for prospective graduate students about pursuing a graduate degree in life sciences. It discusses the skills and career opportunities that come with a graduate degree, including research, teaching, industry careers, and more. It provides tips for applying to graduate school, including identifying suitable supervisors and labs, drafting a strong application, and applying for funding. Overall, it encourages students to pursue graduate education if interested in a career with continual learning where they can contribute to important scientific fields.
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Transitioning to Independence: Tips for Writing NIH Career (K) Award Applicat...HopkinsCFAR
The document provides tips for writing NIH Career (K) award applications, including:
1. It outlines the various K award mechanisms for different career stages from postdoctoral training through assistant professor level.
2. It discusses the application process and identifies important elements of a successful application such as the research plan, career development plan, mentors, and institutional commitment.
3. It emphasizes starting early, getting feedback, and paying attention to eligibility requirements and submission guidelines.
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
How to Anticipate and Plan for an R Grant Application (2020)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
This document provides information to help navigate career development opportunities at the National Institutes of Health (NIH). It describes the various NIH Institutes and Centers and their funding priorities. It also outlines the different types of grants, fellowships, and awards available at different career stages, from training programs to independent research awards. Key resources covered include the NIH RePORTER database to find funded projects, program officers to discuss ideas, and the NIH Research Training website for more details on specific opportunities. The document aims to guide scientists seeking NIH support in identifying the right Institute and program to fit their research area and career stage.
How to Anticipate and Plan for an R Grant Application - 2023UCLA CTSI
CTSI R Workshop: How to Anticipate and Plan for an R Grant Application.
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application. (2022)UCLA CTSI
Carol Mangione provides strategies for early career researchers to successfully transition from a K award to an R01 grant. She emphasizes building relationships at NIH, identifying the best fitting funding opportunities, and making the most of preliminary K award research. Researchers should publish findings, present at conferences, and collaborate with senior scientists. When preparing an R01 application, researchers should clearly outline the proposed project based on significant preliminary findings and check that the research aims have not already been funded.
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
How to Structure the “Approach” Section (Basic Science)UCLA CTSI
CTSI R Workshop: How to Structure the “Approach” Section of a Grant Application
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" [Filler] - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" - 2023UCLA CTSI
This document provides guidance on key sections of an NIH R01 grant application, including Significance, Innovation, and review criteria. It discusses that Significance refers to how the project will advance scientific knowledge or improve clinical practice if successful, not just the importance of the disease topic. Reviewers evaluate the rigor of prior research supporting the project and the applicant's plans to address weaknesses. Innovation can involve novel concepts, approaches, technologies, or new applications of existing methods. The simplified NIH review framework focuses on whether the proposed research should be conducted based on Significance and Approach.
A Tactical Approach to Writing Your Grant Application (HSR) - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application (HSR)
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
Associate Director, UCLA Specialty Training and Advanced Research (STAR) Program
A Tactical Approach to Writing Your Grant Application - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Write the “Specific Aims” Section of a Grant Application (Basic Scienc...UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application (Basic Science
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
NIH Loan Repayment Program (LRP) Info Session - 9/26/23UCLA CTSI
The UCLA CTSI and DGSOM Office of Physician Scientist Career Development held this webinar to provide information on the NIH Loan Repayment Program (LRP). This funding is designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.
Writing the NIH K Award – Research Plan
Presented by
Sumeet S. Chugh, MD
Price Professor and Associate Director, Smidt Heart Institute
Director, Division of Artificial Intelligence in Medicine
Cedars-Sinai Medical Center
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources (2023)UCLA CTSI
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources
Presented by Elizabeta Nemeth, PhD
Professor of Medicine at UCLA
Director, UCLA Center for Iron Disorders
Co-Director, UCLA CTSI KL2 Program
Writing the NIH K Award – Candidate Information and Career Development Plan, ...UCLA CTSI
Writing the NIH K Award – Candidate Information and Career Development Plan,
How Reviewers Evaluate K Awards, and Common Critiques from NIH K Study Sections
Presented by O. Kenrik Duru, MD, MSHS
Professor of Medicine at UCLA
Investigator (Disparities), UCLA CTSI Special Populations
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Mitchell Wong, M.D. Ph.D.
Professor of Medicine
Executive Vice Chair for Research Training in the Department of Medicine.
Director of the CTSI KL2 Program,
Executive co-Director of the UCLA Specialty Training and Advanced Research (STAR) Program,
Co-Director of the UCLA NRSA Primary Care Fellowship
How to Write the “Specific Aims” Section of a Grant Application (Filler 2020)UCLA CTSI
The document provides guidance on writing an effective specific aims page for a research proposal. It should convey excitement about the research, be easily understood without jargon, and make the reviewer want to learn more. The typical structure includes 1-2 paragraphs of background and importance of the topic, prior research, gaps in knowledge, and an overall hypothesis. Specific aims are then listed as bullet points. The writing should avoid jargon, complex language, and criticisms while ensuring each aim can stand alone.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Introduction to AI for Nonprofits with Tapp Network
K99 Award: the NIH "Pathway to Independence"
1. K99/R00 - Awards
“Pathway to Independence”
Chris Evans
310 206 7884
cevans@ucla.edu
1-2 years of
Mentored
Research
3 years of
Independent
Research
+
3. PURPOSE:
K99 - To support Career/Research Transition to a faculty position and provides 1-2 years of mentored
support for, advanced (but not too advanced) postdoctoral research scientists.
R00 - To support the second phase of a Career/Research Transition award and provides 1 -3 years of
independent research support (R00) contingent on securing an independent research position. Award
recipients will hopefully compete successfully for independent R01 support from the NIH during the R00
research transition award period.
Bottom Line
2 years mentored research – move to faculty slot – 3 years R01-like funding
Questions and Answers
https://grants.nih.gov/grants/new_investigators/QsandAs.htm
Blog spot
http://k99advice.blogspot.com
“There’s a lively exchange occurring among scientists on Twitter right now regarding the advice that you need a Cell, Nature, or Science
(CNS) paper in order to land a faculty job.”
4. REQUIREMENTS ELIGIBILITY FOR APPLICATION:
K99 will support non-US citizens but one must be in the US for both training and R00.
Must be at the time of application submission (or resubmission) in postdoctoral training.
Evidence for independence, and therefore lack of eligibility, includes: The candidate has a
full-time faculty position. The candidate received a start-up package for support of his/her
independent research.
Must have a terminal clinical or research doctorate (including Ph.D., M.D., D. O., D.C., N.D.,
D.D.S., D.V.M., Sc.D., D.N.S., Pharm. D.,) or equivalent doctoral degree, or a combined
degree.
no more than 4 years of postdoctoral research experience since completing the
requirements of the doctoral degree in or outside USA (resubmissions must also comply
with this requirement). This time can be extended due to pregnancy, parenting, military
service and other personal issues reducing ability to work. Clinical training time with no
research involvement (e.g., residency training) is not counted against the 4-year limit.
5. Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During
the COVID-19 Pandemic
Release Date: February 4, 2022
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-062.html
Under normal circumstances, individuals must have no more than four years (i.e., 48 months) of postdoctoral research
experience to be eligible to apply for a K99/R00 Pathway to Independence award. NIH will be providing the following
extensions in eligibility for prospective candidates:
Individuals whose final due date for eligibility based on a 48-month eligibility window is February/March 2022 will be
granted a two-receipt cycle extension (roughly eight additional months).
Individuals whose final due date for eligibility based on a 48-month eligibility window is June/July 2022 will be granted a
one-receipt cycle extension (roughly four additional months).
Individuals who have previously received the two-cycle automatic COVID-based eligibility extension for K99 submission are
not eligible for an additional extension.
Implementation
The two-receipt cycle extension in eligibility under this Notice applies only to applicants for a K99/R00 award under one of
the parent Funding Opportunity Announcements (PA-20-187, PA-20-188, and PA-20-189).
For eligible applicants submitting new or resubmission applications, the two-receipt cycle extension will be automatically
accepted by the NIH; no additional documentation is required. However, prospective K99 applicants who wish to receive
non-COVID-related extensions (such as those for childbirth, adoption, family, etc.) must continue to provide relevant
documentation.
6. REQUIREMENTS/ELIGIBILITY FOR R00:
The second (R00) phase provides up to 3 years of independent research support, which is
contingent on satisfactory progress during the K99 phase and an approved, independent,
tenure-track (or equivalent) faculty position.
R00 awards will generally only be made to those K99 PIs who accept independent, tenure-
track (or equivalent) faculty positions in the USA by the end of the K99 award period.
Note: You can’t take your R00 outside of the country (even Canada or Mexico).
NIH can get sticky giving R00 awards for faculty staying in the same institution and with
questionable job titles… getting an independent job is now tough and job seeking needs to
occur soon after receiving the award….
Check with an NIH institute project officer and try to meet at a conference or via zoom!
7. National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Center for Complementary and Integrative Health (NCCIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Library of Medicine (NLM)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
National Institute on Minority Health and Health Disparities (NIMHD)
Special Note: Not all NIH Institutes and Centers participate in Parent Announcements ( for example NINDS does not participate in Clinical Trials).
(CRITCAL – TALK TO PROGRAM STAFF!)
PARTICIPATING INSTITUTES:
8.
9. Make yourself known to a PO and ask advice in the
institute you are applying to!
https://researchtraining.nih.gov/programs/career-development/K99-R00
NIH Funding Opportunity Announcements
The links below provide details on funding amounts period of performance, application
dates and eligibility:
NIH Pathway to Independence Award (Parent K99/R00 - Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PA-18-397.html
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not
Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-398.html
10. What reviewers will look for?
1) Your CV: Good track record – high impact publications –and publications that have primary authorship – add a link
to all your publications. Explain contributions to “team science” multi-author publications. Highlight success in
different environments, advise to highlight objectives of training in personal statement.
2) Preliminary data: innovation, potential impact, rigor of the research project to the NIH institute you are applying to.
This is a training grant and needs to demonstrate good rationale for acquiring new techniques, rigor of
methodologies and creating a base for accomplishing the desired project and transitioning to the ROO phase. Avoid
acronyms explain the importance of the problem and your hypothesis rigorously – get reviewers excited but don’t
oversell and accurately relay impact – remember reviews are unlikely to be your field expertts.
3) Training plan: can be more/just as important than the research ideas. This is a place in which reviewers can get very
picky, especially if they are not swayed by the science. Staying in one location and area of research for all training is
considered a negative – complementary approaches to fulfill your career goals positive. Transitioning to a totally
new field without continuity with past research a difficult sell.
4) Reference letters: obtain from well-established and high-impact researchers in the field. Don’t go to your friends
down the hall – cultivate letters from faculty that are relevant in your area and ask your mentor to help you out.
Compliment weaknesses in your primary mentors CV in areas of research, mentorship and technical expertise.
5) Mentor/training environment is critical. Positives are NIH grants for mentor, training track record (use co-mentor if
any weaknesses), institutional opportunities/cores/seminars/courses etc, different from Ph.D. mentor/environment,
the K99 component has synergism with prior career scientific trajectory.
13. Rigor and Authentication of Reagents:
- Remember sex /gender needs to be addressed
- Ask statisticians at UCLA such as David Elashoff for advice – power analysis etc
- Reagents need to be verified – using an antibody to XXX doesn’t cut it
https://ctsi.ucla.edu/funding/files/view/docs/RigorandReproducibility_Rochester.pdf
https://grants.nih.gov/reproducibility/module_1/presentation.html
14. Case Histories
Note: CTSI have uploader successful applications. Chat with a successful K99 trainee.
15. 1: Bredy TW, Barad M. Social modulation of associative fear learning by pheromone communication. Learn Mem.
2008 Dec 30;16(1):12-8. doi:10.1101/lm.1226009. Print 2009 Jan. PubMed PMID: 19117912; PubMed Central
PMCID: PMC2632855.
2: Bredy TW, Barad M. The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and
reconsolidation of conditioned fear. Learn Mem. 2008Jan 3;15(1):39-45. doi: 10.1101/lm.801108. Print 2008 Jan.
PubMed PMID: 18174372;PubMed Central PMCID: PMC2170514.
3: Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene
promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem. 2007 Apr
6;14(4):268-76. Print 2007Apr. PubMed PMID: 17522015; PubMed Central PMCID: PMC2216532.
4: Bredy TW, Brown RE, Meaney MJ. Effect of resource availability on biparental care, and offspring neural and
behavioral development in the California mouse (Peromyscus californicus). Eur J Neurosci. 2007 Jan;25(2):567-75.
PubMed PMID:17284199.
5: Bredy TW. Behavioural epigenetics and psychiatric disorders. Med Hypotheses. 2007;68(2):453. Epub 2006 Sep
11. PubMed PMID: 16963190.
6: Zhang TY, Bagot R, Parent C, Nesbitt C, Bredy TW, Caldji C, Fish E, AnismanH, Szyf M, Meaney MJ. Maternal
programming of defensive responses through ustained effects on gene expression. Biol Psychol. 2006 Jul;73(1):72-
89. Epub2006 Feb 28. Review. PubMed PMID: 16513241.
7: Bredy TW, Zhang TY, Grant RJ, Diorio J, Meaney MJ. Peripubertal environmental enrichment reverses the effects
of maternal care on hippocampal development and glutamate receptor subunit expression. Eur J Neurosci. 2004
Sep;20(5):1355-62.PubMed PMID: 15341607.
8: Bredy TW, Lee AW, Meaney MJ, Brown RE. Effect of neonatal handling and paternal care on offspring cognitive
development in the monogamous Californiamouse (Peromyscus californicus). Horm Behav. 2004 Jun;46(1):30-8.
PubMed PMID:15215039.
9: Bredy TW, Grant RJ, Champagne DL, Meaney MJ. Maternal care influences neuronal survival in the hippocampus
of the rat. Eur J Neurosci. 2003Nov;18(10):2903-9. PubMed PMID: 14656341.
10: Bredy TW, Humpartzoomian RA, Cain DP, Meaney MJ. Partial reversal of the effect of maternal care on cognitive
function through environmental enrichment. Neuroscience. 2003;118(2):571-6. PubMed PMID: 12699791.
Good pedigree, most first authored papers, consistent productivity (medium-good
impact), not NIDA obvious, but NIDA interested in learning and memory
processes/plasticity, different labs PhD and postdoc.
TIMOTHY W. BREDY
Associate Professor,
The University of
Queensland, Brisbane,
Australia
Ph.D., McGill
University Then Postdoc
at UCLA. R00 - UCI
16. Kate Wassum Ph. D.,
Professor Psychology, UCLA
PhD/Postdoc UCLA
Primary : Learning and
Behavior
Secondary: Behavioral
Neuroscience
1: Wassum KM, Ostlund SB, Balleine BW, Maidment NT. Differential dependence o fPavlovian incentive
motivation and instrumental incentive learning processes on dopamine signaling. Learn Mem. 2011 Jun
21;18(7):475-83.
2: Wassum KM, Cely IC, Balleine BW, Maidment NT. Micro-opioid receptor activation in the basolateral
amygdala mediates the learning of increases but not decreases in the incentive value of a food reward. J
Neurosci. 2011 Feb 2;31(5):1591-9.
3: Ostlund SB, Wassum KM, Murphy NP, Balleine BW, Maidment NT. Extracellular dopamine levels in
striatal subregions track shifts in motivation and response cost during instrumental conditioning. J Neurosci.
2011 Jan 5;31(1):200-7.
4: Wassum KM, Cely IC, Maidment NT, Balleine BW. Disruption of endogenous opioid activity during
instrumental learning enhances habit acquisition. Neuroscience.2009 Oct 20;163(3):770-80. doi:
10.1016/j.neuroscience.2009.06.071. Epub 2009 Jul18. PubMed PMID: 19619616; PubMed Central PMCID:
PMC3065789.
5: Wassum KM, Ostlund SB, Maidment NT, Balleine BW. Distinct opioid circuits determine the palatability
and the desirability of rewarding events. Proc NatlAcad Sci U S A. 2009 Jul 28;106(30):12512-7. doi:
10.1073/pnas.0905874106. Epub2009 Jul 13. PubMed PMID: 19597155; PubMed Central PMCID:
PMC2718390.
6: Wassum KM, Evans CJ. International Narcotics Research Conference - 39thAnnual Meeting. IDrugs. 2008
Sep;11(9):646-9. PubMed PMID: 18763214.
7: Wassum KM, Tolosa VM, Wang J, Walker E, Monbouquette HG, Maidment NT. SiliconWafer-Based
Platinum Microelectrode Array Biosensor for Near Real-Time Measurement of Glutamate in Vivo. Sensors
(Basel). 2008;8(8):5023-5036. PubMedPMID: 19543440; PubMed Central PMCID: PMC2699285.
8: Wightman RM, Heien ML, Wassum KM, Sombers LA, Aragona BJ, Khan AS, AriansenJL, Cheer JF, Phillips
PE, Carelli RM. Dopamine release is heterogeneous within microenvironments of the rat nucleus
accumbens. Eur J Neurosci. 2007Oct;26(7):2046-54. Epub 2007 Sep 14. PubMed PMID: 17868375.
9: Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM. Phasic
dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci. 2007
Jan 24;27(4):791-5. PubMedPMID: 17251418.
10: Cheer JF, Wassum KM, Wightman RM. Cannabinoid modulation of electrically evoked pH and oxygen
transients in the nucleus accumbens of awake rats. JNeurochem. 2006 May;97(4):1145-54. PubMed PMID:
16686693.
11: Heien ML, Khan AS, Ariansen JL, Cheer JF, Phillips PE, Wassum KM, WightmanRM. Real-time
measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc Natl Acad Sci U S A.
2005 Jul 19;102(29):10023-8. Epub 2005Jul 8. PubMed PMID: 16006505; PubMed Central PMCID:
PMC1177422.
12: Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM. Cannabinoids enhance subsecond
dopamine release in the nucleus accumbens of awake rats. J Neurosci.2004 May 5;24(18):4393-400.
PubMed PMID: 15128853.
Good pedigree, many 1st
authored papers, consistent
productivity (high impact),
NIDA-related research. CV
exceptionally strong, many
awards……?????? No K99
17. I got a score 38 on my K99,
Here is the text from her summary statement that she allowed me to share:
Enthusiasm is tempered by the fact that the proposal is not really distinguished from the candidate’s
previous work in this environment. The training does not really appear to add to the applicant’s already
extensive abilities and experiences gained in this same environment with the same
mentors. ………………………….The case for additional training in these disciplines was difficult to
discern. Although the principal investigator has taken advantage of the thriving scientific resources at
UCLA during her graduate and postdoctoral training, the application was unclear how further training in
the same environment would achieve the goals of the K99. For example, the proposed K99 mentor, Dr
Maidment, is co-author on all the applicant’s publications from her time at UCLA, including the
predoctoral tenure. Similarly, the predoctoral mentor, Dr Balleine, continues as co-author on papers
described in the application as postdoctoral projects. …………………………….Drug studies will occur in the
independent phase so no obvious training in neuropharmacology will occur under this plan. Do not see
that the extra training proposed advances the applicant’s career prospects. The applicant already has
publications/work on methods proposed, i.e. use of Glu biosensors. The applicant also appears to have
extensive behavioral training. Does not seem appropriate for a K99 – the application seems to be
continuation of training rather than seeking really new opportunities. Continuing in same environment –
proposed mentor has been an important part of all her graduate and postdoc work to date and is senior
author on many of her publications.
18. Amynah Pradhan PhD
Canadian Citizen
PhD CNRS France,
Postdoc UCLA
Assistant Professor
Department of Psychiatry
University of Illinois
Good Pedigree, most 1st
authored papers, impact is
med (2010 high), NIDA
relevance – pain (opioids) – 6
years out of post-doc
motherhood (rules changed
from 5 to 4 years after
graduation recently).
1: Lutz PE, Pradhan AA, Goeldner C, Kieffer BL. Sequential and opposingalterations of
5-HT(1A) receptor function during withdrawal from chronic morphine. Eur
Neuropsychopharmacol. 2011 Nov;21(11):835-40.
2: Pradhan AA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A, Evans C,Kieffer BL.
Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward
analgesic tolerance. J Neurosci. 2010 Dec 8;30(49):16459-68.
3: Pradhan AA, Yu XH, Laird JM. Modality of hyperalgesia tested, not type ofnerve
damage, predicts pharmacological sensitivity in rat models of neuropathic pain. Eur J
Pain. 2010 May;14(5):503-9.
4: Pradhan AA. Botulinum toxin: An emerging therapy in female bladder outlet
obstruction. Indian J Urol. 2009 Jul;25(3):318-20.
6: Pradhan AA, Gogate PR. Degradation of p-nitrophenol using acoustic cavitation and
Fenton chemistry. J Hazard Mater. 2010 Jan 15;173(1-3):517-22.
7: Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Massotte D,
Gavériaux-Ruff C, Kieffer BL. In vivo delta opioid receptor internalization controls
behavioral effects of agonists. PLoS One.2009;4(5):e5425.
8: Pradhan AA, Siau C, Constantin A, Clarke PB. Chronic morphine administration
results in tolerance to delta opioid receptor-mediated antinociception. Neuroscience.
2006 Aug 25;141(2):947-54.
9: Pradhan AA, Clarke PB. Pharmacologically selective block of mu
opioidantinociception by peptide nucleic acid antisense in absence of detectable
exvivo knockdown. Eur J Pharmacol. 2005 Jan 4;506(3):229-36.
10: Pradhan AA, Clarke PB. Comparison between delta-opioid receptor functional
response and autoradiographic labeling in rat brain and spinal cord. J CompNeurol.
2005 Jan 24;481(4):416-26. Pu
11: Pradhan AA, Levine MA. Warfarin use in atrial fibrillation: A random samplesurvey
of family physician beliefs and preferences. Can J Clin Pharmacol. 2002
Winter;9(4):199-202.
12: Pradhan AA, Cumming P, Clarke PB. [125I]Epibatidine-labelled nicotinicreceptors
in the extended striatum and cerebral cortex: lack of association with serotonergic
afferents. Brain Res. 2002 Nov 8;954(2):227-36. PubMed PMID:12414106.
19. Anna Taylor, PhD
PhD Canada
Canadian Citizen
Post-Doc UCLA
Assistant Professor
University of Alberta
Good Pedigree, most 1st authored
papers, impact was med-high,
NIDA relevance – pain (opioids) – 6
years out of post-doc.
Funded 2 years after review.
Weird things happen!
Cahill CM, Walwyn W, Taylor AMW, Pradhan AAA, Evans CJ. (2016). Allostatic mechanisms of opioid tolerance
beyond desensitization and downregulation. Trends Pharmacol Sci 37(11):963-976
Taylor AMW, Mehrabani S, Liu S, Taylor AJ, Cahill CM. (2016) Topography of microglial activation in sensory
and affect related brain regions in chronic pain. J Neurosci Res
Taylor AM, Becker S, Schweinhardt P, Cahill C. (2016) Mesolimbic dopamine signaling in acute and chronic
pain: implications for motivation, analgesia, and addiction. Pain 157(6):1194-8.
Taylor AMW, Castonguay A, Ghogha A, Vayssiere P, Pradhan AAA, Mehrabani S, Xue L, Wu J, Levitt P, De
Koninck Y, Evans CJ, Cahill CM. (2016) Neuroimmune regulation of GABAergic neurons within the ventral
tegmental area during withdrawal from chronic morphine. Neuropsychopharmacology, 41:949-959
Taylor AM, Castonguay A, Taylor, A, Murphy N, Ghogha A, Cook C, Xue L, Olmstead M, De Koninck Y, Evans C,
Cahill C (2015). Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci 35(22):8442-8450
Charrua A, Pinto R, Taylor A, Canelas A, Ribeiro-da-Silva A, Cruz CD, Birder LA, Cruz F (2015) Can the
adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A
clinical and experimental study. Neurourol Urodyn. Epub.
Cahill CM, Taylor AM, Cook C, Ong E, Moron JA, Evans CJ (2014). Does the kappa opioid receptor system
contribute to pain aversion? Front Pharmacol 15;5:253
Taylor AMW, Roberts KW, Pradhan AA, Walwyn W, Lutfy K, Carroll FI, Cahill CM, Evans CJ (2014). Kappa
opioid receptor-mediated analgesia is blocked by a delta opioid receptor agonist. British Journal of
Pharmacology, 172(2):e102334
Taylor AMW, Murphy NP, Evans CJ, Cahill CM (2014) Correlation between ventral striatal catecholamine
content and nociceptive thresholds in neuropathic mice. J Pain 15(8): 878-885.
Taylor, AMW. (2013) Pain and reward: How the affective-motivational system is perturbed in chronic pain.
Postdoctoral Research Journal. Vol 1, No.2.
Taylor, AMW and Ribeiro-da-Silva A. (2012). Consequences of the ablation of non-peptidergic afferents in an
animal model of trigeminal neuropathic pain. Pain. 153: 1311-1319.
Farmer, M.A., Taylor, AMW, Bailey, A.L., McIntyre, L.C., Milagrosa, Z.E., Crissman, H.P., Bennet, G.J., Ribeiro-
da-Silva, A., Binik, T.M., and Mogil, J.S. (2011) Recurrent vulvovaginal candidiasis as an etiology of provoked
vestibulodynia. Science Translational Medicine. 101ra91.
Cahill, C.M. and Taylor, AMW. (2011) A piece of the puzzle is revealed for delta opioid analgesia. Pain. 152
(6): 1217-1218.
Taylor, AMW. and Ribeiro-da-Silva, A. (2011). GDNF levels in the lower lip skin in rat model of trigeminal
neuropathic pain: Implications for non-peptidergic fiber re-innervation and parasympathetic sprouting. Pain.
52 (7): 1502-1510.
Taylor, AMW, Peleshok, J.C., and Ribeiro-da-Silva, A. (2009) Distribution of P2X3-immunoreactive fibers in
hairy and glabrous skin of the rat. J Comp Neurol. (514):555-566.
Riedl, M.S., Schnell, S.A., Overland, A.C., Chabot-Dore, A.J., Taylor, AMW, Ribeiro-da-Silva, A., Elde, R.P.,
Wilcox, G.L., and Stone, L.S. (2009) Coexpression of alpha2a adrenergic and delta opioid receptors in
substance P-Containing terminals in rat dorsal horn. J Comp Neurol. (513) 385-398.
Holdridge, S.C., Armstrong, S.A., Taylor, AMW, and Cahill, C.M. (2007) Behavioral and morphological evidence
for the involvement of glial cell activation of delta opioid receptor function: implications for the development
of opioid tolerance. Mol Pain. 3:7.